The biopharmaceutical company received FDA approval for a first-of-its-kind treatment for a rare neurodevelopmental disease.

Nebius rises as the so-called neocloud recently announced it would raise its on-demand rates for a range of AI chips.

Palantir CEO Alex Karp says AI companies are concerned about the liability risk posed by their product and that some ...

Anthropic could be public in a matter of weeks. Wall Street—and the world—are nowhere near ready for what’s to come.

Complete Ai Funds High Conviction US Equity AI-Managed ETF funds overview by Barron's. View the HIAI funds market news ...

Holtec Nuclear said the move was because of “market conditions.” The market is shaky because the nuclear euphoria of the pas ...

Stocks were on track to open higher on Thursday as oil prices retreated and investors got over the worst of their worries ...

The Federal Reserve’s rate increase and Chairman Kevin Warsh’s messaging helped reassure investors about the central bank’s ...

Armstrong stock has been hit by concerns about tighter spending in the construction sector. Those worries are overblown.

The paper losses on a large Bank of America bond portfolio could have widened by more than $10 billion to over $90 billion in ...

Snap is bringing SPECS Intelligence to its smart glasses, iPhones, and Macs as competition in consumer AI intensifies.

Goldman Sachs Group stock has been the worst performer of big banks lately and came under renewed pressure after comments ...